This protocol is judged by an institutional evaluation board, an independent team that critiques any medical trials involving individuals. If a review involves a Agenda I drug, when the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) range with the FDA.And since the copyright